GLYCOMIRA, LLC
Transforming Cancer Therapy
Salt Lake City, United States · Founded 2016
- Headquarters
- Salt Lake City, Utah
- Founded
- 2016
- Business Model
- B2G
- Website
- glycomira.com
About
GlycoMira Therapeutics is a clinical-stage biopharmaceutical company developing innate immune system modulators based on polysaccharides that naturally occur in the body. Their lead drug candidate, GM-1111, targets unmet needs in solid tumor treatment, radiation-induced injuries such as Oral Mucositis and Acute Radiation Syndrome, and chronic rhinosinusitis. The company's R&D is funded through NIH awards and private investment.
Summary
GLYCOMIRA, LLC is a Biotech company based in Salt Lake City, United States, founded in 2016.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/glycomira-llc"><img src="https://indexed.vc/api/badge/company/glycomira-llc" alt="GLYCOMIRA, LLC on Indexed.vc" width="260" height="76" /></a>